Investigating the theragnostic potential of 131I-caerin peptide in thyroid cancer.
Sign Up to like & getrecommendations! Published in 2020 at "Hellenic journal of nuclear medicine"
DOI: 10.1967/s002449912003
Abstract: OBJECTIVE Caerin is a new peptide with tumour toxicity and its uptake by tumour cells is independent of the sodium iodide symporter (NIS). Thyroid cancer is the most common cancers of endocrine malignancy. Radioiodine (131I)-refractory… read more here.
Keywords: caerin; peptide; 131i caerin; thyroid cancer ... See more keywords
131I-Caerin 1.1 and 131I-Caerin 1.9 for the treatment of non-small-cell lung cancer
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.861206
Abstract: Objective To investigate the effect of the 131I-labeled high-affinity peptides Caerin 1.1 and Caerin 1.9 for the treatment of A549 human NSCLC cells. Methods ① 3-[4,5-Dimethylthiazole-2-yl]-2,5-diphenyltetrazolium bromide (MTT) and plate clone formation assays were performed… read more here.
Keywords: 131i labeled; caerin; 131i caerin; labeled caerin ... See more keywords